Stephen Squinto, PhD

Stephen Squinto, PhD is an Executive Partner at OrbiMed Advisors LLC, an investment firm, who brings over 25 years of biotechnology industry experience. Previously, Dr. Squinto co-founded Alexion Pharmaceuticals, a biotechnology company, and served as its Executive Vice President and Chief Global Operations Officer, and prior to 2013 as its Global Head of Research and Development. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools.

Dr. Squinto holds a PhD in biochemistry and biophysics and a BA in chemistry from Loyola University of Chicago.